Monopar Therapeutics Inc.
(MNPR - NASDAQ)
79,57 USD
📋 Profilo Aziendale

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

|